{
  "docId": "019de076-9103-7399-8bed-9b1b1a8b182a",
  "docSlug": "93c36ca1f8977b3a70b566ce0ab54138",
  "documentTitle": "argenx SE | Investor Conference Presentation Deck | 27 slides",
  "authorId": "argenx-se",
  "authorName": "argenx",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2024-01-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 18,
  "pageCount": 27,
  "prevPage": 17,
  "nextPage": 19,
  "slideType": "key_takeaways",
  "function": "analyze_data",
  "density": "dense",
  "nDataPoints": 6,
  "notes": "Kaplan-Meier survival curve showing probability of being retreated with IVIg.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de076-9103-7399-8bed-9b1b1a8b182a/18",
  "deckHref": "/decks/019de076-9103-7399-8bed-9b1b1a8b182a",
  "deckJsonHref": "/decks/019de076-9103-7399-8bed-9b1b1a8b182a.json",
  "deckAnchorHref": "/decks/019de076-9103-7399-8bed-9b1b1a8b182a#slide-18",
  "components": [
    {
      "bbox": {
        "h": 0.5,
        "w": 0.55,
        "x": 0.05,
        "y": 0.22
      },
      "kind": "chart",
      "text": "Kaplan-Meier curve of probability of being retreated with IVIg",
      "attrs": null,
      "subkind": "line",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "34e58526-e9f4-4f3b-8af6-78b18fa75751",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.9,
        "x": 0.05,
        "y": 0.78
      },
      "kind": "list",
      "text": "94% of treated patients rated their condition improved; 8/9 placebo patients had no change or worsened. Empasiprubart demonstrated improvement on 6/6 efficacy measurements. Safety profile consistent with Phase 1 data.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a084ece6-9e0e-4dce-af7a-566a92cb5c0a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.4,
        "w": 0.3,
        "x": 0.65,
        "y": 0.25
      },
      "kind": "metric",
      "text": "91% reduction in need for IVIg rescue with empasiprubart",
      "attrs": null,
      "subkind": "big-number",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "abc5da3f-5cb2-4695-9dab-b7900edf4fbb",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 1,
        "x": 0,
        "y": 0.95
      },
      "kind": "title",
      "text": "Cohort 2 is ongoing; results to inform dose for Phase 3 study initiation",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9c84ef54-2485-467d-8dc0-81cd330094cb",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.9,
        "x": 0.05,
        "y": 0.05
      },
      "kind": "title",
      "text": "Empasiprubart has Potential to Transform MMN",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c573d69a-60d1-4b26-a99e-6e0b7a769a22",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Big Idea Formula",
      "slug": "big-idea-formula",
      "agent": "Storyteller",
      "layer": "slide",
      "matchId": "e3dc0264-7a15-43ce-9932-4abce072db06",
      "evidence": "Empasiprubart has Potential to Transform MMN",
      "confidence": 0.7
    },
    {
      "name": "Storytelling: audience calibration",
      "slug": "audience",
      "agent": "storyteller",
      "layer": "slide",
      "matchId": "47c30ff2-5b64-43a7-ad13-f16f60bc73cd",
      "evidence": "94% of treated patients rated their condition improved",
      "confidence": 0.5
    }
  ],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 20,
      "from": 15,
      "beatId": "9b26e95b-08d2-43e3-9516-c1a147c99880",
      "arcName": "Rags to Riches",
      "arcSlug": "rags-to-riches",
      "beatName": "The Breakthrough",
      "beatSlug": "rags-to-riches-the-breakthrough",
      "evidence": "Pipeline horizon and potential for transformation",
      "position": 3,
      "confidence": 0.8,
      "parentBeatName": "Turn",
      "parentBeatSlug": "turn"
    }
  ],
  "loops": [
    {
      "to": 20,
      "from": 15,
      "name": "Quick Win Big Bet",
      "slug": "47-quick-win-big-bet",
      "bestFor": "Transformation planning, 100-day plans, resource allocation",
      "matchId": "febbca6c-7f97-4066-8898-43ab685a76f2",
      "evidence": "Pipeline horizon and potential for transformation",
      "position": 1,
      "objective": "Quick wins and big bets in pipeline development",
      "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap",
      "confidence": 0.6,
      "description": "Separate initiatives into immediate wins and longer-term strategic bets"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}